Dr. Young is a clinically-oriented diagnostic physician with clinical expertise in the diagnosis of hematologic cancers, including tumors of the bone marrow, lymphoid tissue, spleen and pre-malignant hematologic conditions. Another area of interest is blood cancer classification with molecular and genetic profiling.

Dr. Young serves as the Director of Hematopathology and Vice Chair of Research at the Duke University School of Medicine, providing diagnostic services and relevant specialized testing for patients with various types of acute and chronic leukemia, lymphoma and benign hematologic disorders. He specializes in the diagnosis of hematological disorders, including acute and chronic leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, B and T-cell lymphomas, Hodgkin lymphoma, cutaneous and orbital lymphomas and benign bone marrow and lymph node disorders.

Dr. Young provides persistent support for the physician-scientist program and Blood Cancer Pathology program in the department and cancer center, and performs comprehensive clinical and research functions, including bone marrow, lymphoma pathology, clinical flow cytometry, cytogenetics, and molecular diagnostics.